Controlled Study of Guanfacine XR in ADHD

Abstract

A multicenter, double-blind, placebo-controlled, fixed-dosage escalation study of an extended release formulation of guanfacine is reported from the Massachusetts General Hospital, Boston, and other centers in the US and UK.

Keywords

• guanfacine xr
• blood pressure
• ecg abnormalities